The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Targeting cancer stem cell plasticity in triple-negative breast cancer”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Asma Jan, Shazia Sofi, Nusrat Jan, Manzoor Ahmad Mir. An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer, Future Oncology. 2025; 21: 715. https://doi.org/10.1080/14796694.2025.2461443 |
|
2 |
2025 |
Desh Deepak Singh, Dharmendra Kumar Yadav, Dongyun Shin. Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer, Cells. 2025; 14: 1482. https://doi.org/10.3390/cells14181482 |
|
3 |
2026 |
Krishna Murari, Neelam Singla, Riya Mishra, Asif Ahmad Bhat, Riya Thapa, Neeraj Patel, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta. 2026; 85. https://doi.org/10.1016/B978-0-443-33349-1.00007-7 |
|
4 |
2025 |
María Rosado-Sanz, Nuria Martínez-Alarcón, Adrián Abellán-Soriano, Raúl Golfe, Eva M. Trinidad, Jaime Font de Mora. Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies, Biomedicines. 2025; 13: 1945. https://doi.org/10.3390/biomedicines13081945 |
|
5 |
2025 |
Arka Saha, Avri Ben-Ze’ev. 2025; https://doi.org/10.1016/bs.acr.2025.06.001 |
|
6 |
2025 |
Durgesh N. Patil, Khushwant S. Yadav. Bridging Therapeutic Strategies in Triple-Negative Breast Cancer: Integrating Combination therapies, Antibody-drug conjugates, and Nanocarriers, Journal of Drug Delivery Science and Technology. 2025; 107703107703. https://doi.org/10.1016/j.jddst.2025.107703 |
|
7 |
2025 |
Mustafa B. A. Djamgoz, Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective, Stem Cell Reviews and Reports. 2025; 21: 337. https://doi.org/10.1007/s12015-024-10809-0 |